Capecitabine in breast cancer: current status.

Clinical breast cancer

Volumn 1, Issue 4, 2001, Pages

  Smorenburg, C H ^a   Bontenbal, M ^a   Verweij, J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; CAPECITABINE; DEOXYCYTIDINE; DRUG DERIVATIVE; PRODRUG;

BREAST TUMOR; CLINICAL TRIAL; FEMALE; HUMAN; REVIEW;

ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CLINICAL TRIALS; DEOXYCYTIDINE; FEMALE; HUMANS; PRODRUGS;

MLCS; MLOWN;

EID: 18244427309     PISSN: 15268209     EISSN: None     Source Type: Journal    
DOI: 10.3816/cbc.2001.n.003     Document Type: Review

References (45)